St. Jude Medical, Inc. was a global medical device company headquartered in St. Paul, Minnesota, specializing in products for cardiac rhythm management, atrial fibrillation, heart failure, structural heart, and neuromodulation. Founded in 1976, it grew to become a significant player in the medical technology industry, developing life-saving and life-improving devices. In January 2017, St. Jude Medical was acquired by Abbott Laboratories, and its operations and product lines were integrated into Abbott's existing medical device businesses. The acquisition aimed to create a premier medical device leader with a strong position in cardiovascular and neuromodulation markets.
Served as the primary corporate office, housing executive leadership, global administration, R&D, and operational oversight for St. Jude Medical's worldwide activities.
The campus was a significant corporate complex in St. Paul, designed to support a large workforce involved in high-tech medical device development and manufacturing. It included office buildings and specialized R&D labs.
The work culture at St. Jude Medical was generally described as innovative, patient-focused, and collaborative, driven by the mission to develop advanced medical technologies. Employees were often deeply committed to the impact of their work on patients' lives.
The St. Paul headquarters was central to St. Jude Medical's global strategy, product innovation, and growth for decades, establishing it as a leader in medical devices.
Prior to its acquisition by Abbott, St. Jude Medical had a robust global presence, with operations spanning over 100 countries. This included direct sales forces, distributors, R&D centers, and manufacturing facilities in North America, Europe, Asia-Pacific, Latin America, and the Middle East. The company supported healthcare professionals and patients globally with its cardiovascular and neuromodulation devices and therapies through clinical support, training, and education programs.
One Lillehei Plaza
St. Paul
Minnesota
USA
Address: 15900 Valley View Ct, Sylmar, CA 91342, USA
Key U.S. operational and innovation center for specific product divisions.
Address: 6901 Preston Rd, Plano, TX 75024, USA
Center of excellence for neuromodulation technologies.
Address: The Corporate Village, Da Vincilaan 11, Box F1, 1930 Zaventem, Belgium (Example historical address)
EMEA regional headquarters and operational hub.
Address: Undisclosed specific address for general listing, multiple facilities in the area.
Part of the broader Minnesota-based innovation and operational cluster for the company.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, St. Jude Medical' leadership includes:
St. Jude Medical has been backed by several prominent investors over the years, including:
St. Jude Medical was acquired by Abbott Laboratories in January 2017. Significant executive changes occurred as part of this acquisition, with many St. Jude Medical executives transitioning to roles within Abbott or departing. There have been no executive hires or exits for St. Jude Medical as an independent entity in the last 12 months, as it no longer operates independently.
Discover the tools St. Jude Medical uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
The following email formats were commonly used by St. Jude Medical prior to its acquisition by Abbott in 2017. These email addresses are no longer active.
Common formats included [first_initial][last]@sjm.com and [first].[last]@sjm.com
Format
jdoe@sjm.com or john.doe@sjm.com
Example
0%
Success rate
Abbott Newsroom • January 4, 2017
Abbott announced it has successfully completed the acquisition of St. Jude Medical, Inc., establishing the company as a leader in the medical device arena. The transaction provides expanded opportunities for future growth and is an important part of the company's ongoing effort to develop a strong, diverse portfolio of devices, diagnostics, nutritionals and branded generic pharmaceuticals....more
FDA (via PR Newswire archive) • August 23, 2016
St. Jude Medical announced U.S. Food and Drug Administration (FDA) approval of an expanded magnetic resonance imaging (MRI) conditional labeling for its Prodigy™ Chronic Pain System with SelectArea™ programming. This approval significantly expanded options for patients with chronic pain requiring a spinal cord stimulation (SCS) system who also need access to MRI....more
FDA • January 9, 2017
The FDA and St. Jude Medical (now Abbott) informed the public about cybersecurity vulnerabilities related to St. Jude Medical's implantable cardiac devices and the Merlin@home Transmitter. A software patch was developed and released to mitigate these risks....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including St. Jude Medical, are just a search away.